ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #9,468Gold OA

Journal of Virus Eradication

Acronym:jve
•
Abbreviation (ISO):J VIRUS ERAD
•
Identifier (ISSN):2055-6640(Print)/2055-6659(Online)
•
Publisher:Elsevier
Clarivate IF (2026)
2.8↑ +0.8
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2020–2026)

Clarivate IF trend for Journal of Virus Eradication

WoS Q3
13682.8220203.720215.1520225.520233.52024220252.82026
Annual Impact Factor Metric
Current (2026):2.8
Scopus SJR & RankScopus Q2
0.621
#9,468

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
22

22 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate28.6%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
19articles/year
100% Gold OA•92.59% Original Research

Aims & Scope

Journal of Virus Eradication (acronym: jve, abbr: J VIRUS ERAD, ISSN: 2055-6640) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier in England. The periodical holds a Journal Impact Factor (JIF) of 2.80, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.621 (Q2), an H-index of 22.

Topics Covered (Recognized by AI)
Medicine94.8%Biology92.3%Virology85.3%Immunology82.3%Family medicine70.5%Human immunodeficiency virus (HIV)68%Genetics55.2%Internal medicine34.3%Chemistry33.9%Biochemistry30.6%Computer science25.9%Virus24.3%Pathology21.6%Psychology20.5%Engineering20.3%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

IMMUNOLOGY

Q3
Rank121/183
IndexSCIE
JCRSCIE2026

INFECTIOUS DISEASES

Q2
Rank67/141
IndexSCIE
JCRSCIE2026

VIROLOGY

Q3
Rank23/44
IndexSCIE
JCISCIE2026

IMMUNOLOGY

Q3
Rank124/183
IndexSCIE
JCISCIE2026

INFECTIOUS DISEASES

Q3
Rank89/141
IndexSCIE
JCISCIE2026

VIROLOGY

Q3
Rank26/44
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.8
Articles / Year13
Total Citations0
2025
IF2
Articles / Year35
Total Citations27
2024
IF3.5
Articles / Year188
Total Citations112
2023
IF5.5
Articles / Year45
Total Citations259
2022
IF5.148
Articles / Year238
Total Citations294

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #9,468Scopus Q2SCImago Profile
Scopus Coverage:2015-2026
Scopus Broad Areas:Immunology and MicrobiologyMedicine
Scopus Citation Rank (SJR)Q2
0.621

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
2.29

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,308 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations233
3-Year Documents109
Citable Documents94

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate46.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

EpidemiologyQ2
Infectious DiseasesQ2
Public Health, Environmental and Occupational HealthQ2
VirologyQ2
ImmunologyQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 28.6%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区IMMUNOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Virus Eradication (acronym: jve, abbr: J VIRUS ERAD, ISSN: 2055-6640) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier in England. The periodical holds a Journal Impact Factor (JIF) of 2.80, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.621 (Q2), an H-index of 22.

The journal enforces rigorous peer evaluation with an annual output of approximately 19 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,308 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
Elsevier
Publication Language
English
Frequency
Periodic
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
1 MOUNTVIEW CT, 310 FRIERN BARNET LN, LONDON, ENGLAND, N20 0LD

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: ece79586-b3cd-4eaf-b3a4-b1ee7d6699a1
Database Updated: 2026-10-16